Publicacións en colaboración con investigadores/as de Hospital Clinic Barcelona (47)

2023

  1. Impact of Age at the Time of the First ST-Elevation Myocardial Infarction on 10-Year Outcomes (from the EXAMINATION-EXTEND Trial)

    American Journal of Cardiology, Vol. 190, pp. 32-40

  2. Right heart remodelling after bicaval TricValve implantation in patients with severe tricuspid regurgitation

    EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, Vol. 19, Núm. 5, pp. e450-e452

2022

  1. A Score to Assess Mortality After Percutaneous Mitral Valve Repair

    Journal of the American College of Cardiology, Vol. 79, Núm. 6, pp. 562-573

  2. Angiography-derived physiology guidance vs usual care in an All-comers PCI population treated with the healing-targeted supreme stent and Ticagrelor monotherapy: PIONEER IV trial design

    American Heart Journal, Vol. 246, pp. 32-43

  3. Conservative, surgical, and percutaneous treatment for mitral regurgitation shortly after acute myocardial infarction

    European heart journal, Vol. 43, Núm. 7, pp. 641-650

  4. Five-year outcomes after state-of-the-art percutaneous coronary revascularization in patients with de novo three-vessel disease: Final results of the SYNTAX II study

    European Heart Journal, Vol. 43, Núm. 13, pp. 1307-1316

  5. Impact of Diabetes on 10-Year Outcomes Following ST-Segment–Elevation Myocardial Infarction: Insights From the EXAMINATION-EXTEND Trial

    Journal of the American Heart Association, Vol. 11, Núm. 23

  6. Magnesium-based resorbable scaffold vs permanent metallic sirolimus-eluting stent in patients with ST-segment elevation myocardial infarction: 3-year results of the MAGSTEMI randomised controlled trial

    EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, Vol. 18, Núm. 5, pp. e389-e396

  7. Prognostic Impact of Nutritional Status After Transcatheter Edge-to-Edge Mitral Valve Repair: The MIVNUT Registry

    Journal of the American Heart Association, Vol. 11, Núm. 20

  8. Sex Differences in 10-Year Outcomes Following STEMI: A Subanalysis From the EXAMINATION-EXTEND Trial

    JACC: Cardiovascular Interventions, Vol. 15, Núm. 19, pp. 1965-1973

2021

  1. Safety and feasibility of mitraclip implantation in patients with acute mitral regurgitation after recent myocardial infarction and severe left ventricle dysfunction

    Journal of Clinical Medicine, Vol. 10, Núm. 9

  2. Use of MitraClip for mitral valve repair in patients with acute mitral regurgitation following acute myocardial infarction: Effect of cardiogenic shock on outcomes (IREMMI Registry)

    Catheterization and Cardiovascular Interventions, Vol. 97, Núm. 6, pp. 1259-1267

2020

  1. Bioresorbable scaffolds versus permanent sirolimus-eluting stents in patients with st-segment elevation myocardial infarction: Vascular healing outcomes from the magstemi trial

    EuroIntervention, Vol. 16, Núm. 11, pp. E913-E921

  2. Major bleeding predictors in patients with left atrial appendage closure: The iberian registry ii

    Journal of Clinical Medicine, Vol. 9, Núm. 7, pp. 1-11

  3. Transcatheter mitral valve repair in patients with acute myocardial infarction: Insights from the European Registry of MitraClip in Acute Mitral Regurgitation following an acute myocardial infarction (EREMMI)

    EuroIntervention, Vol. 15, Núm. 14, pp. 1248-1250

2019

  1. Long-term Event Reduction After Left Atrial Appendage Closure. Results of the Iberian Registry II

    Revista Espanola de Cardiologia, Vol. 72, Núm. 6, pp. 449-455

  2. Long-term impact of diabetes in patients with ST-segment elevation myocardial infarction: Insights from the EXAMINATION randomized trial

    Catheterization and Cardiovascular Interventions, Vol. 94, Núm. 7, pp. 917-925

  3. MAGnesium-based bioresorbable scaffold and vasomotor function in patients with acute ST segment elevation myocardial infarction: The MAGSTEMI trial: Rationale and design

    Catheterization and Cardiovascular Interventions, Vol. 93, Núm. 1, pp. 64-70

  4. Magnesium-Based Resorbable Scaffold Versus Permanent Metallic Sirolimus-Eluting Stent in Patients with ST-Segment Elevation Myocardial Infarction: The MAGSTEMI Randomized Clinical Trial

    Circulation, Vol. 140, Núm. 23, pp. 1904-1916

2018

  1. Correlates of non-target vessel-related adverse events in patients with ST-segment elevation myocardial infarction: Insights from five-year follow-up of the EXAMINATION trial

    EuroIntervention, Vol. 13, Núm. 16, pp. 1939-1945